Fig. 3

Overall distribution of time (months) to invasive fungal disease stratified by haematological malignancy and haematopoietic stem cell transplantation. ALL, acute lymphoblastic leukaemia; allo-HSCT, allogeneic-haematopoietic stem cell transplantation; AML, acute myeloid leukaemia; auto-HSCT, autologous-haematopoietic stem cell transplantation; CLL, chronic lymphoblastic leukaemia; CML, chronic myeloid leukaemia; HL, Hodgkin lymphoma; HM, haematological malignancy; IFD, invasive fungal disease; IQR, inter-quartile range; MM, multiple myeloma; NHL, non-Hodgkin lymphoma. Median [IQR] time (months) to IFD: ALL, 5 [2 – 12]; AML, 3 [1 – 10]; CLL, 19 [4 – 45]; CML, 12 [2 – 25]; HL, 15 [1 – 29]; MM, 22 [7 – 36]; NHL, 6 [2 -18]; allogeneic-HSCT, 4 [2 – 18]; autologous-HSCT, 7 [5 – 10]